DEGRADATION OF CYCLIN-DEPENDENT KINASE 9 (CDK9) BY CONJUGATION OF CDK9 INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE (Fri, 27 Oct 2017)
>> Read More

DEGRADATION OF CYCLIN-DEPENDENT KINASE 4/6 (CDK4/6) BY CONJUGATION OF CDK4/6 INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE (Fri, 27 Oct 2017)
>> Read More

DEGRADATION OF CYCLIN-DEPENDENT KINASE 8 (CDK8) BY CONJUGATION OF CDK8 INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE (Fri, 27 Oct 2017)
>> Read More

BIFUNCTIONAL MOLECULES FOR DEGRADATION OF EGFR AND METHODS OF USE (Fri, 27 Oct 2017)
>> Read More

PYRIMIDO-DIAZEPINONE KINASE SCAFFOLD COMPOUNDS AND METHODS OF TREATING PI3K-MEDIATED DISORDERS (Fri, 13 Oct 2017)
>> Read More

PYRIMIDO-DIAZEPINONE COMPOUNDS AND METHODS OF TREATING DISORDERS (Fri, 06 Oct 2017)
>> Read More

PYRAZOL-3-ONES THAT ACTIVATE PRO-APOPTOTIC BAX (Fri, 29 Sep 2017)
>> Read More

STAPLED INTRACELLULAR-TARGETING ANTIMICROBIAL PEPTIDES TO TREAT INFECTION (Sat, 09 Sep 2017)
>> Read More

METHOD FOR GENERATING CELL-PENETRATING STAPLED PEPTIDES THAT LACK NONSPECIFIC MEMBRANE-LYTIC PROPERTIES FOR THERAPEUTIC TARGETING (Fri, 01 Sep 2017)
>> Read More

ANTIFUNGAL COMPOUNDS AND USES THEREOF (Fri, 25 Aug 2017)
>> Read More

INHIBITORS OF HIV-1 ENTRY AND METHODS OF USE THEREOF (Fri, 18 Aug 2017)
>> Read More

THIAZOLYL-CONTAINING COMPOUNDS FOR TREATING PROLIFERATIVE DISEASES (Fri, 18 Aug 2017)
>> Read More

COMPOSITIONS AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF T-CELL EXHAUSTION USING CD39 BIOMARKERS AND MODULATORS (Fri, 18 Aug 2017)
>> Read More

USES OF SALT-INDUCIBLE KINASE (SIK) INHIBITORS (Fri, 11 Aug 2017)
>> Read More

COMPOUNDS, COMPOSITIONS AND METHODS FOR CANCER PATIENT STRATIFICATION AND CANCER TREATMENT (Fri, 11 Aug 2017)
>> Read More

METHODS FOR TREATING BRAIN METASTASES USING COMBINATIONS OF ANTI-P13K AND ANTI-mTOR AGENTS (Fri, 04 Aug 2017)
>> Read More

MACROCYCLIC KINASE INHIBITORS AND USES THEREOF (Fri, 21 Jul 2017)
>> Read More

IMIDAZOLYL KINASE INHIBITORS AND USES THEREOF (Fri, 21 Jul 2017)
>> Read More

BIFUNCTIONAL MOLECULES FOR HER3 DEGRADATION AND METHODS OF USE (Fri, 07 Jul 2017)
>> Read More

BIFUNCTIONAL COMPOUNDS FOR HER3 DEGRADATION AND METHODS OF USE (Fri, 07 Jul 2017)
>> Read More

METHODS OF USE OF A CLASS llA HDAC INHIBITOR (Fri, 30 Jun 2017)
>> Read More

IMMUNE CELL-TARGETED PARTICLES (Fri, 30 Jun 2017)
>> Read More

STABILIZED ALPHA HELICAL PEPTIDES AND USES THEREOF (Fri, 09 Jun 2017)
>> Read More

BIVALENT BROMODOMAIN INHIBTORS AND USES THEREOF (Fri, 02 Jun 2017)
>> Read More

DIHYDROPTERIDINONE DERIVATIVES AND USES THEREOF (Fri, 26 May 2017)
>> Read More

TUMOR SUPPRESSOR AND ONCOGENE BIOMARKERS PREDICTIVE OF ANTI-IMMUNE CHECKPOINT INHIBITOR RESPONSE (Fri, 12 May 2017)
>> Read More

METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF METABOLIC DISORDERS USING PM20D1 AND N-LIPIDATED AMINO ACIDS (Fri, 05 May 2017)
>> Read More

COMPOSITIONS AND METHODS FOR TARGETING CANCER-SPECIFIC SEQUENCE VARIATIONS (Fri, 05 May 2017)
>> Read More

Thiazolyl-containing compounds for treating proliferative diseases (Fri, 05 May 2017)
>> Read More

INHIBITORS OF ALK AND SRPK AND METHODS OF USE (Fri, 31 Mar 2017)
>> Read More

Humanized Monoclonal Antibodies and Methodsof Use (Fri, 17 Mar 2017)
>> Read More

INHIBITORS OF CYCLIN-DEPENDENT KINASES (Fri, 17 Mar 2017)
>> Read More

CYANO THIENOTRIAZOLODIAZEPINES AND USES THEREOF (Fri, 17 Mar 2017)
>> Read More

COMPOSITIONS AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF CANCER USING NFS1 BIOMARKERS AND MODULATORS (Fri, 24 Feb 2017)
>> Read More

FUSION PROTEINS FOR TREATING CANCER AND RELATED METHODS (Fri, 24 Feb 2017)
>> Read More

HYDROPHOBICALLY TAGGED JANUS KINASE INHIBITORS AND USES THEREOF (Fri, 17 Feb 2017)
>> Read More

JANUS KINASE INHIBITORS AND USES THEREOF (Fri, 17 Feb 2017)
>> Read More

HIGH-THROUGHPUT STRUCTURE DETERMINATION USING NUCLEIC ACID CALIPERS (Fri, 17 Feb 2017)
>> Read More

COMPOSITIONS AND METHODS FOR CANCER EXPRESSING PDE3A OR SLFN12 (Fri, 17 Feb 2017)
>> Read More

TUNABLE ENDOGENOUS PROTEIN DEGRADATION (Fri, 10 Feb 2017)
>> Read More

TARGETED PROTEIN DEGRADATION TO ATTENUATE ADOPTIVE T-CELL THERAPY ASSOCIATED ADVERSE INFLAMMATORY RESPONSES (Fri, 10 Feb 2017)
>> Read More

METHODS TO INDUCE TARGETED PROTEIN DEGRADATION THROUGH BIFUNCTIONAL MOLECULES (Fri, 10 Feb 2017)
>> Read More

Compositions and Methods for Treating Neoplasia, Inflammatory Disease and Other Disorders (Fri, 03 Feb 2017)
>> Read More

Uses of salt-inducible kinase (SIK) inhibitors (Fri, 03 Feb 2017)
>> Read More

METHODS AND COMPOSITIONS FOR SPECIFIC MODULATION OF MCL-1 (Thu, 02 Feb 2017)
>> Read More

NOVEL PYRIMIDINES AS EGFR INHIBITORS AND METHODS OF TREATING DISORDERS (Fri, 27 Jan 2017)
>> Read More

STABILIZED ANTI-MICROBIAL PEPTIDES (Fri, 20 Jan 2017)
>> Read More

Imidazolyl kinase inhibitors and uses thereof (Fri, 20 Jan 2017)
>> Read More

Macrocyclic kinase inhibitors and uses thereof (Fri, 20 Jan 2017)
>> Read More

USES OF DIAZEPANE DERIVATIVES (Fri, 13 Jan 2017)
>> Read More

METHODS TO INDUCE TARGETED PROTEIN DEGRADATION THROUGH BIFUNCTIONAL MOLECULES (Fri, 13 Jan 2017)
>> Read More

TUMOR AND MICROENVIRONMENT GENE EXPRESSION, COMPOSITIONS OF MATTER AND METHODS OF USE THEREOF (Fri, 06 Jan 2017)
>> Read More

INHIBITORS OF EGFR AND METHODS OF USE THEREOF (Fri, 06 Jan 2017)
>> Read More

STABILIZED ANTI-MICROBIAL PEPTIDES (Fri, 06 Jan 2017)
>> Read More

Activating JAK kinase biomarkers predictive of anti-immune checkpoint inhibitor response (Fri, 06 Jan 2017)
>> Read More

FUSED BICYCLIC PYRIMIDINE DERIVATIVES AND USES THEREOF (Fri, 30 Dec 2016)
>> Read More

4,6-PYRIMIDINYLENE DERIVATIVES AND USES THEREOF (Fri, 30 Dec 2016)
>> Read More

INHIBITORS OF C-JUN-N-TERMINAL KINASE (JNK) (Fri, 23 Dec 2016)
>> Read More

SIGNATURES AND DETERMINANTS ASSOCIATED WITH PROSTATE CANCER PROGRESSION AND METHODS OF USE THEREOF (Fri, 16 Dec 2016)
>> Read More

CD4-MIMETIC SMALL MOLECULES SENSITIZE HUMAN IMMUNODEFICIENCY VIRUS TO VACCINE-ELICITED ANTIBODIES (Fri, 16 Dec 2016)
>> Read More

COMPOUNDS AND METHODS FOR TREATING CANCER (Fri, 09 Dec 2016)
>> Read More

Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders (Fri, 02 Dec 2016)
>> Read More

Protein-based particles for drug delivery (Fri, 02 Dec 2016)
>> Read More

Tumor suppressor and oncogene biomarkers predictive of anti-immune checkpoint inhibitor response (Fri, 02 Dec 2016)
>> Read More

DIAMINOPYRIMIDINE BENZENESULFONE DERIVATIVES AND USES THEREOF (Fri, 18 Nov 2016)
>> Read More

METHODS TO TREAT LYMPHOPLASMACYTIC LYMPHOMA (Fri, 04 Nov 2016)
>> Read More

Male contraceptive compositions and methods of use (Fri, 04 Nov 2016)
>> Read More

METHODS TO TREAT LYMPHOPLASMACYTIC LYMPHOMA (Fri, 28 Oct 2016)
>> Read More

Kynurenine Pathway Biomarkers Predictive of Anti-Immune Checkpoint Inhibitor Response (Fri, 14 Oct 2016)
>> Read More

BIOMARKER FOR MELK ACTIVITY AND METHODS OF USING SAME (Fri, 07 Oct 2016)
>> Read More

INHIBITORS OF CYCLIN-DEPENDENT KINASES (Fri, 07 Oct 2016)
>> Read More

STK4 INHIBITORS FOR TREATMENT OF HEMATOLOGIC MALIGNANCIES (Fri, 07 Oct 2016)
>> Read More

Inhibitors of cyclin-dependent kinases (Fri, 07 Oct 2016)
>> Read More

NUCLEIC ACID NANOSTRUCTURES FOR IN VIVO AGENT DELIVERY (Fri, 23 Sep 2016)
>> Read More

POLYCYCLIC INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) (Fri, 16 Sep 2016)
>> Read More

Pyrazol-3-ones That Activate Pro-apoptotic BAX (Fri, 16 Sep 2016)
>> Read More

HETEROAROMATIC COMPOUNDS USEFUL FOR THE TREATMENT OF PROLFERATIVE DISEASES (Fri, 16 Sep 2016)
>> Read More

METHOD FOR PREPARING LARGAZOLE ANALOGS AND USES THEREOF (Fri, 16 Sep 2016)
>> Read More

PD-L2 BIOMARKERS PREDICTIVE OF PD-1 PATHWAY INHIBITOR RESPONSES IN ESOPHAGOGASTRIC CANCERS (Fri, 16 Sep 2016)
>> Read More

SYNTHESIS AND UTILITY OF NEW CAPGROUP LARGAZOLE ANALOGS (Fri, 16 Sep 2016)
>> Read More

Synthesis and utility of new capgroup largazole analogs (Fri, 16 Sep 2016)
>> Read More

Method for preparing largazole analogs and uses thereof (Fri, 16 Sep 2016)
>> Read More

PD-L2 biomarkers predictive of PD-1 pathway inhibitor responses in esophagogastric cancers (Fri, 16 Sep 2016)
>> Read More

SALICYLATE INHIBITORS OF MELK AND METHODS OF USE (Sat, 10 Sep 2016)
>> Read More

TRICYCLIC KINASE INHIBITORS OF MELK AND METHODS OF USE (Sat, 10 Sep 2016)
>> Read More

Tricyclic kinase inhibitors of MELK and methods of use (Sat, 10 Sep 2016)
>> Read More

METHODS TO INDUCE TARGETED PROTEIN DEGRADATION THROUGH BIFUNCTIONAL MOLECULES (Fri, 26 Aug 2016)
>> Read More

COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS (Fri, 19 Aug 2016)
>> Read More

Methods to induce targeted protein degradation through bifunctional molecules (Fri, 19 Aug 2016)
>> Read More

Methods to induce targeted protein degradation through bifunctional molecules (Fri, 19 Aug 2016)
>> Read More

LRRK2 INHIBITORS AND METHODS OF MAKING AND USING THE SAME (Fri, 19 Aug 2016)
>> Read More

Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD) (Fri, 12 Aug 2016)
>> Read More

INHIBITORS OF PHOSPHOGLYCERATE DEHYDROGENASE (PHGDH) AND USES THEREOF (Fri, 22 Jul 2016)
>> Read More

INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) (Fri, 01 Jul 2016)
>> Read More

METHODS TO INDUCE TARGETED PROTEIN DEGRADATION THROUGH BIFUNCTIONAL MOLECULES (Fri, 01 Jul 2016)
>> Read More

NOVEL PYRIMIDINES AS EGFR INHIBITORS AND METHODS OF TREATING DISORDERS (Fri, 01 Jul 2016)
>> Read More

Inhibitors of cyclin-dependent kinase 7 (CDK7) (Fri, 01 Jul 2016)
>> Read More

COMPOSITIONS AND METHODS FOR INCREASING ERYTHROPOIETIN (EPO) PRODUCTION (Fri, 24 Jun 2016)
>> Read More

Methods to induce targeted protein degradation through bifunctional molecules (Fri, 24 Jun 2016)
>> Read More

Kinase inhibitors for the treatment of disease (Fri, 24 Jun 2016)
>> Read More

INHIBITORS OF TRANSCRIPTION FACTORS AND USES THEREOF (Fri, 17 Jun 2016)
>> Read More

Chemical Modulators of Pro-Apoptotic BAX and BCL-2 Polypeptides (Fri, 17 Jun 2016)
>> Read More

Stabilized insulinotropic peptides and methods of use (Fri, 10 Jun 2016)
>> Read More

BRAF MUTATIONS CONFERRING RESISTANCE TO BRAF INHIBITORS (Thu, 09 Jun 2016)
>> Read More

Type II RAF kinase inhibitors (Wed, 08 Jun 2016)
>> Read More

COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS (Fri, 03 Jun 2016)
>> Read More

COMPOSITIONS AND METHODS FOR TREATING CANCER (Fri, 27 May 2016)
>> Read More

Histone deacetylase inhibitors (Fri, 27 May 2016)
>> Read More

ANTI-GALECTIN ANTIBODY BIOMARKERS PREDICTIVE OF ANTI-IMMUNE CHECKPOINT AND ANTI-ANGIOGENESIS RESPONSES (Fri, 13 May 2016)
>> Read More

FOLATE-CONJUGATED MOLECULES FOR DELIVERY OF TOXIC SMALL MOLECULE INHIBITORS TO CANCER CELLS AND METHODS OF USE (Fri, 13 May 2016)
>> Read More

EZH2 INHIBITORS AND USES THEREOF (Fri, 13 May 2016)
>> Read More

Anti-galectin antibody biomarkers predictive of anti-immune checkpoint and anti-angiogenesis responses (Fri, 13 May 2016)
>> Read More

EZH2 inhibitors and uses thereof (Fri, 13 May 2016)
>> Read More

INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) (Fri, 06 May 2016)
>> Read More

Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders (Fri, 06 May 2016)
>> Read More

Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7) (Fri, 06 May 2016)
>> Read More

Heteroaromatic compounds useful for the treatment of proliferative diseases (Fri, 06 May 2016)
>> Read More

THIAZOLYL-CONTAINING COMPOUNDS FOR TREATING PROLIFERATIVE DISEASES (Fri, 29 Apr 2016)
>> Read More

COMPOSITIONS AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF T-CELL EXHAUSTION USING CD39 BIOMARKERS AND MODULATORS (Fri, 22 Apr 2016)
>> Read More

Compositions and methods for identification, assessment, prevention, and treatment of T-cell exhaustion using CD39 biomarkers and modulators (Fri, 22 Apr 2016)
>> Read More

ANGIOPOIETIN-2 BIOMARKERS PREDICTIVE OF ANTI-IMMUNE CHECKPOINT RESPONSE (Fri, 15 Apr 2016)
>> Read More

MULTIPLE-VARIABLE IL-2 DOSE REGIMEN FOR TREATING IMMUNE DISORDERS (Fri, 15 Apr 2016)
>> Read More

Multiple-variable IL-2 dose regimen for treating immune disorders (Fri, 15 Apr 2016)
>> Read More

Angiopoietin-2 biomarkers predictive of anti-immune checkpoint response (Fri, 15 Apr 2016)
>> Read More

WIREFRAME NANOSTRUCTURES (Fri, 25 Mar 2016)
>> Read More

TYPE II RAF KINASE INHIBITORS (Fri, 11 Mar 2016)
>> Read More

DOT1L inhibitors (Fri, 04 Mar 2016)
>> Read More

TYPE II RAF KINASE INHIBITORS (Fri, 19 Feb 2016)
>> Read More

RAS INHIBITORS AND USES THEREOF (Fri, 19 Feb 2016)
>> Read More

COATED PARTICLES FOR DRUG DELIVERY (Fri, 19 Feb 2016)
>> Read More

INHIBITORS OF HIV-1 ENTRY AND METHODS OF USE THEREOF (Fri, 19 Feb 2016)
>> Read More

USES OF SALT-INDUCIBLE KINASE (SIK) INHIBITORS (Fri, 12 Feb 2016)
>> Read More

DIHYDROPTERIDINONE DERIVATIVES AND USES THEREOF (Fri, 12 Feb 2016)
>> Read More

Inhibitors of transcription factors and uses thereof (Fri, 12 Feb 2016)
>> Read More

BH4 STABILIZED PEPTIDES AND USES THEREOF (Fri, 05 Feb 2016)
>> Read More

Pyrimido-diazepinone compounds and methods of treating disorders (Fri, 29 Jan 2016)
>> Read More

IMIDAZOLYL KINASE INHIBITORS AND USES THEREOF (Fri, 29 Jan 2016)
>> Read More

MACROCYCLIC KINASE INHIBITORS AND USES THEREOF (Fri, 29 Jan 2016)
>> Read More

Kinase inhibitors for the treatment of disease (Fri, 29 Jan 2016)
>> Read More

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CANCER (Fri, 22 Jan 2016)
>> Read More

PROTEIN-BASED PARTICLES FOR DRUG DELIVERY (Fri, 20 Nov 2015)
>> Read More

COMPOSITIONS AND METHODS FOR IDENTIFICATION ASSESSSMENT, PREVENTION, AND TREATMENT OF CANCER USING NFS1 BIOMARKERS AND MODULATORS (Fri, 13 Nov 2015)
>> Read More

FUSION PROTEINS FOR TREATING CANCER AND RELATED METHODS (Fri, 06 Nov 2015)
>> Read More

Class- and isoform-specific HDAC inhibitors and uses thereof (Fri, 30 Oct 2015)
>> Read More

HIGH-THROUGHPUT STRUCTURE DETERMINATION USING NUCLEIC ACID CALIPERS (Fri, 30 Oct 2015)
>> Read More

JANUS KINASE INHIBITORS AND USES THEREOF (Fri, 30 Oct 2015)
>> Read More

HYDROPHOBICALLY TAGGED JANUS KINASE INHIBITORS AND USES THEREOF (Fri, 30 Oct 2015)
>> Read More

TUMOR SUPPRESSOR AND ONCOGENE BIOMARKERS PREDICTIVE OF ANTI-IMMUNE CHECKPOINT INHIBITOR RESPONSE (Fri, 30 Oct 2015)
>> Read More

Pyrrol-1-yl benzoic acid derivatives useful as myc inhibitors (Fri, 16 Oct 2015)
>> Read More

Hydrophobically tagged small molecules as inducers of protein degradation (Fri, 02 Oct 2015)
>> Read More

Methods and compositions for specific modulation of MCL-1 (Fri, 04 Sep 2015)
>> Read More

P13K-MTORC1-S6K1 SIGNALING PATHWAY BIOMARKERS PREDICTIVE OF ANTI-CANCER RESPONSES (Fri, 21 Aug 2015)
>> Read More

SELF-ASSEMBLY OF NUCLEIC ACID NANOSTRUCTURES (Fri, 07 Aug 2015)
>> Read More

DIAMINOPYRIMIDINE BENZENESULFONE DERIVATIVES AND USES THEREOF (Fri, 07 Aug 2015)
>> Read More

DIAZEPANE DERIVATIVES AND USES THEREOF (Fri, 07 Aug 2015)
>> Read More

USES OF DIAZEPANE DERIVATIVES (Fri, 07 Aug 2015)
>> Read More

DIHYDROPTERIDINONE DERIVATIVES AND USES THEREOF (Fri, 07 Aug 2015)
>> Read More

ANTIBODIES AGAINST THE MUC1-C/EXTRACELLULAR DOMAIN (MUC1-C/ECD) (Fri, 07 Aug 2015)
>> Read More

Thienotriazolodiazepine compounds for treating neoplasia (Thu, 06 Aug 2015)
>> Read More

SELECTIVE INHIBITORS OF HISTONE DEACETYLASE ISOFORM 6 AND METHODS THEREOF (Fri, 17 Jul 2015)
>> Read More

ANTI-PROLIFERATIVE COMPOUNDS AND USES THEREOF (Fri, 10 Jul 2015)
>> Read More

METHODS TO TREAT LYMPHOPLASMACYTIC LYMPHOMA (Fri, 19 Jun 2015)
>> Read More

MUC-1 cytoplasmic domain peptides as inhibitors of cancer (Fri, 05 Jun 2015)
>> Read More

Compositions and methods for treating neoplasia, inflammatory disease and other disorders (Fri, 05 Jun 2015)
>> Read More

Compositions and methods for treating leukemia (Fri, 05 Jun 2015)
>> Read More

Metabolomic profiling defines oncogenes driving prostate tumors (Fri, 05 Jun 2015)
>> Read More

KYNURENINE PATHWAY BIOMARKERS PREDICTIVE OF ANTI-IMMUNE CHECKPOINT INHIBITOR RESPONSE (Fri, 29 May 2015)
>> Read More

BIOMARKER FOR MELK ACTIVITY AND METHODS OF USING SAME (Fri, 22 May 2015)
>> Read More

NUCLEIC ACID NANOSTRUCTURES FOR IN VIVO AGENT DELIVERY (Fri, 15 May 2015)
>> Read More

Methods for diagnosing and treating oncogenic kras-associated cancer (Fri, 08 May 2015)
>> Read More

TARGETING THE GLUTAMINE TO PYRUVATE PATHWAY FOR TREATMENT OF ONCOGENIC KRAS-ASSOCIATED CANCER (Fri, 24 Apr 2015)
>> Read More

HETEROAROMATIC COMPOUNDS USEFUL FOR THE TREATMENT OF PROLFERATIVE DISEASES (Fri, 24 Apr 2015)
>> Read More

POLYCYCLIC INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) (Fri, 24 Apr 2015)
>> Read More

Compositions and methods for treating neoplasia, inflammatory disease and other disorders (Fri, 24 Apr 2015)
>> Read More

Fused 2-aminothiazole compounds (Fri, 03 Apr 2015)
>> Read More

SMALL MOLECULE MYRISTATE INHIBITORS OF BCR-ABL AND METHODS OF USE (Fri, 03 Apr 2015)
>> Read More

Photoactivatable caged tamoxifen and tamoxifen derivative molecules and methods of use thereof (Fri, 03 Apr 2015)
>> Read More

STABILIZED ALPHA HELICAL PEPTIDES AND USES THEREOF (Fri, 20 Mar 2015)
>> Read More

INHIBITION OF MCL-1 AND/OR BFL-1/A1 (Fri, 20 Feb 2015)
>> Read More

SIK INHIBITOR FOR USE IN A METHOD OF TREATING AN INFLAMMATORY AND/OR IMMUNE DISORDER (Fri, 13 Feb 2015)
>> Read More

Histone deacetylase inhibitors (Fri, 06 Feb 2015)
>> Read More

INHIBITORS OF TRANSCRIPTION FACTORS AND USES THEREOF (Fri, 30 Jan 2015)
>> Read More

KINASE INHIBITORS FOR THE TREATMENT OF DISEASE (Fri, 16 Jan 2015)
>> Read More

Collateral gene inactivation biomarkers and targets for cancer therapy (Fri, 26 Dec 2014)
>> Read More

Stabilized Antiviral Fusion Helices (Fri, 19 Dec 2014)
>> Read More

Targeting the glutamine to pyruvate pathway for treatment of oncogenic Kras-associated cancer (Fri, 19 Dec 2014)
>> Read More

Pyrazol-3-ones that activate pro-apoptotic BAX (Fri, 05 Dec 2014)
>> Read More

CD4-mimetic inhibitors of HIV-1 entry and methods of use thereof (Fri, 28 Nov 2014)
>> Read More

ANTAGONISTS OF MUC1 (Fri, 31 Oct 2014)
>> Read More

METHOD OF INHIBITING HAMARTOMA TUMOR CELLS (Fri, 17 Oct 2014)
>> Read More

Inhibitors of c-Jun-<i>N</i>-terminal kinase (JNK) (Fri, 17 Oct 2014)
>> Read More

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CANCER (Fri, 10 Oct 2014)
>> Read More

Inhibition of MCL-1 and/or BFL-1/A1 (Fri, 10 Oct 2014)
>> Read More

Stabilized alpha helical peptides and uses thereof (Fri, 03 Oct 2014)
>> Read More

RAS INHIBITORS AND USES THEREOF (Fri, 03 Oct 2014)
>> Read More

METHODS OF TREATING CANCER (Fri, 03 Oct 2014)
>> Read More

COMPOSITIONS AND METHODS FOR TREATING CANCER (Fri, 03 Oct 2014)
>> Read More

RAS INHIBITORS AND USES THEREOF (Fri, 03 Oct 2014)
>> Read More

BH4 STABILIZED PEPTIDES AND USES THEREOF (Fri, 19 Sep 2014)
>> Read More

PYRIMIDO-DIAZEPINONE COMPOUNDS AND METHODS OF TREATING DISORDERS (Fri, 19 Sep 2014)
>> Read More

ZNF365/ZFP365 Biomarker Predictive of Anti-Cancer Response (Fri, 22 Aug 2014)
>> Read More

Inhibition of inflammation using antagonists of MUC1 (Fri, 04 Jul 2014)
>> Read More

Stabilized antiviral fusion helices (Fri, 04 Jul 2014)
>> Read More

Inhibitors of c-Jun-N-Terminal Kinase (JNK) (Fri, 04 Jul 2014)
>> Read More

METABOLOMIC PROFILING DEFINES ONCOGENES DRIVING PROSTATE TUMORS (Fri, 13 Jun 2014)
>> Read More

Screening method for BRAF inhibitors (Fri, 06 Jun 2014)
>> Read More

PYRROL-1 -YL BENZOIC ACID DERIVATES USEFUL AS MYC INHIBITORS (Fri, 09 May 2014)
>> Read More

Muc-1 cytoplasmic domain peptides as inhibitors of cancer (Thu, 08 May 2014)
>> Read More

Pyrazol-3-ones that activate pro-apoptotic BAX (Fri, 02 May 2014)
>> Read More

TARGETING DEREGULATED WNT SIGNALING IN CANCER USING STABILIZED ALPHA-HELICES OF BCL-9 (Fri, 25 Apr 2014)
>> Read More

INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) (Fri, 25 Apr 2014)
>> Read More

HYDROPHOBICALLY TAGGED SMALL MOLECULES AS INDUCERS OF PROTEIN DEGRADATION (Fri, 25 Apr 2014)
>> Read More

HISTONE DEACETYLASE INHIBITORS AND METHODS OF USE THEREOF (Fri, 18 Apr 2014)
>> Read More

Kinase inhibitors and methods of use thereof (Fri, 18 Apr 2014)
>> Read More

GSK3 INHIBITORS AND METHODS OF USE THEREOF (Fri, 18 Apr 2014)
>> Read More

Method for preparing largazole analogs and uses thereof (Fri, 04 Apr 2014)
>> Read More

Compositions and methods for increasing erythropoietin (EPO) production (Fri, 24 Jan 2014)
>> Read More

Signatures and determinants associated with prostate cancer progression and methods of use thereof (Fri, 17 Jan 2014)
>> Read More

Compositions and Methods for Treating Leukemia (Fri, 10 Jan 2014)
>> Read More

COMPOUNDS AND METHODS FOR TARGETING LEUKEMIC STEM CELLS (Fri, 20 Dec 2013)
>> Read More

Deacetylase inhibitors and uses thereof (Fri, 13 Dec 2013)
>> Read More

Signatures and determinants associated with cancer and methods of use thereof (Fri, 06 Dec 2013)
>> Read More

TARGETING THE GLUTAMINE TO PYRUVATE PATHWAY FOR TREATMENT OF ONCOGENIC KRAS-ASSOCIATED CANCER (Fri, 29 Nov 2013)
>> Read More

Targeting deregulated WNT signaling in cancer using stabilized alpha-helices of BCL-9 (Fri, 25 Oct 2013)
>> Read More

MUC1 AND GALECTIN-3 (Fri, 18 Oct 2013)
>> Read More

TRPV4 ANTAGONIST AND METHODS OF USE THEREOF (Fri, 11 Oct 2013)
>> Read More

SMALL MOLECULE PRINTING (Fri, 04 Oct 2013)
>> Read More

COMPOSITIONS, KITS, AND METHODS FOR THE GENERATION OF IMMUNOGLOBULIN SEQUENCES (Fri, 04 Oct 2013)
>> Read More

INHIBITION OF MCL-1 AND/OR BFL-1/A1 (Fri, 27 Sep 2013)
>> Read More

Humanized monoclonal antibodies and methods of use (Fri, 20 Sep 2013)
>> Read More

A SIK INHIBITOR FOR USE IN A METHOD OF TREATING AN INFLAMMATORY AND/OR IMMUNE DISORDER (Fri, 20 Sep 2013)
>> Read More

Method of inhibiting hamartoma tumor cells (Fri, 23 Aug 2013)
>> Read More

Male contraceptive compositions and methods of use (Fri, 16 Aug 2013)
>> Read More

Indazole compounds and their uses (Fri, 19 Jul 2013)
>> Read More

Compositions and methods for treating neoplasia, inflammatory disease and other disorders (Fri, 19 Jul 2013)
>> Read More

STABILIZED ANTIVIRAL FUSION HELICES (Fri, 05 Jul 2013)
>> Read More

METHODS FOR DIAGNOSING AND TREATING ONCOGENIC KRAS-ASSOCIATED CANCER (Fri, 28 Jun 2013)
>> Read More

Stabilized insulinotropic peptides and methods of use (Fri, 21 Jun 2013)
>> Read More

COLLATERAL GENE INACTIVATION BIOMARKERS AND TARGETS FOR CANCER THERAPY (Fri, 21 Jun 2013)
>> Read More

CD4-MIMETIC INHIBITORS OF HIV-1 ENTRY AND METHODS OF USE THEREOF (Fri, 21 Jun 2013)
>> Read More

MEK1 Mutation Conferring Resistance to RAF and MEK Inhibitors (Fri, 07 Jun 2013)
>> Read More

INHIBITORS OF C-JUN-N-TERMINAL KINASE (JNK) (Fri, 24 May 2013)
>> Read More

ZNF365/ZFP365 BIOMARKER PREDICTIVE OF ANTI-CANCER RESPONSE (Fri, 19 Apr 2013)
>> Read More

PYRAZOL-3-ONES THAT ACTIVATE PRO-APOPTOTIC BAX (Fri, 19 Apr 2013)
>> Read More

COMPOSITIONS AND THEIR USE IN TREATING NEOPLASIA, INFLAMMATORY DISEASE AND OTHER DISORDERS (Thu, 28 Mar 2013)
>> Read More

Soluble mTOR complexes and modulators thereof (Fri, 22 Mar 2013)
>> Read More

MUC1 LIGAND TRAPS FOR USE IN TREATING CANCERS (Fri, 22 Feb 2013)
>> Read More

ANTI-MUC1 ANTIBODIES FOR CANCER DIAGNOSTICS (Fri, 15 Feb 2013)
>> Read More

COMPOUNDS AND COMPOSITIONS THEREOF FOR TREATING NEOPLASIA, INFLAMMATORY DISEASE AND OTHER DISORDERS (Mon, 04 Feb 2013)
>> Read More

Bifunctional histone deacetylase inhibitors (Fri, 18 Jan 2013)
>> Read More

Compositions and methods for treating leukemia (Fri, 11 Jan 2013)
>> Read More

Compositions and methods for treating neoplasia, inflammatory disease and other disorders (Fri, 11 Jan 2013)
>> Read More

BRAF mutations conferring resistance to BRAF inhibitors (Fri, 04 Jan 2013)
>> Read More

SIGNATURES AND DETERMINANTS ASSOCIATED WITH PROSTATE CANCER PROGRESSION AND METHODS OF USE THEREOF (Fri, 04 Jan 2013)
>> Read More

BRAF MUTATIONS CONFERRING RESISTANCE TO BRAF INHIBITORS (Thu, 03 Jan 2013)
>> Read More

SELECTIVE INHIBITORS OF HISTONE DEACETYLASE ISOFORM 6 AND METHODS THEREOF (Fri, 28 Dec 2012)
>> Read More

SELECTIVE INHIBITORS OF HISTONE DEACETYLASE ISOFORM 6 AND METHODS THEREOF (Fri, 28 Dec 2012)
>> Read More

BIOMARKER FOR PKC-IOTA ACTIVITY AND METHODS OF USING SAME (Fri, 21 Dec 2012)
>> Read More

Humanized monoclonal antibodies and methods of use (Fri, 21 Dec 2012)
>> Read More

Stabilized insulinotropic peptides and methods of use (Fri, 14 Dec 2012)
>> Read More

A MEK 1 mutation conferring resistance to RAF and MEK inhibitors (Fri, 07 Dec 2012)
>> Read More

Method for preparing largazole analogs and uses thereof (Fri, 19 Oct 2012)
>> Read More

TARGETING DEREGULATED WNT SIGNALING IN CANCER USING STABILIZED ALPHA-HELICES OF BCL-9 (Fri, 19 Oct 2012)
>> Read More

Indazole compounds and their uses (Fri, 21 Sep 2012)
>> Read More

HIGH-THROUGHPUT ASSAYS TO PROBE LEUKEMIA WITHIN THE STROMAL NICHE (Fri, 24 Aug 2012)
>> Read More

HISTONE DEACETYLASE INHIBITORS AND METHODS OF USE THEREOF (Fri, 24 Aug 2012)
>> Read More

COMPOUNDS AND METHODS FOR TARGETING LEUKEMIC STEM CELLS (Fri, 24 Aug 2012)
>> Read More

BRAF mutations conferring resistance to BRAF inhibitors (Fri, 24 Aug 2012)
>> Read More

Class- and isoform-specific HDAC inhibitors and uses thereof (Fri, 17 Aug 2012)
>> Read More

METHOD OF INHIBITING HAMARTOMA TUMOR CELLS (Fri, 17 Aug 2012)
>> Read More

Compositions,kits, and methods for identification, assessment, prevention, and therapy of metabolic disorders (Fri, 17 Aug 2012)
>> Read More

Small molecules for the modulation of MCL-1 and methods of modulatiing cell death, cell division, cell differentiation and methods of treating disorders (Fri, 10 Aug 2012)
>> Read More

Stabilized alpha helical peptides and uses thereof (Fri, 10 Aug 2012)
>> Read More

Histone deacetylase inhibitors (Fri, 03 Aug 2012)
>> Read More

MUC-1 cytoplasmic domain peptides as inhibitors of cancer (Fri, 06 Jul 2012)
>> Read More

Type II Raf kinase inhibitors (Fri, 22 Jun 2012)
>> Read More

SIGNATURES AND DETERMINANTS ASSOCIATED WITH CANCER AND METHODS OF USE THEREOF (Fri, 08 Jun 2012)
>> Read More

Small molecule CD4 mimetics and uses thereof (Fri, 18 May 2012)
>> Read More

Fused 2-aminothiazole compounds (Fri, 13 Apr 2012)
>> Read More

Stabilized alpha helical peptides and uses thereof (Fri, 06 Apr 2012)
>> Read More

Antagonists of MUC1 (Fri, 24 Feb 2012)
>> Read More

Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders (Fri, 17 Feb 2012)
>> Read More

Conformationally stabilized HIV envelope immunogens (Fri, 10 Feb 2012)
>> Read More

MEK mutations conferring resistance to MEK inhibitors (Fri, 20 Jan 2012)
>> Read More

STABILIZED INSULINOTROPIC PEPTIDES AND METHODS OF USE (Fri, 13 Jan 2012)
>> Read More

Compositions and methods for the treatment of viral infections (Fri, 30 Dec 2011)
>> Read More

Small molecule myristate inhibitors of BCR-ABL and methods of use (Fri, 23 Dec 2011)
>> Read More

Phosphorylated RaIA (Fri, 16 Dec 2011)
>> Read More

A MEK 1 MUTATION CONFERRING RESISTANCE TO RAF AND MEK INHIBITORS (Fri, 16 Dec 2011)
>> Read More

A MEK1 MUTATION CONFERRING RESISTANCE TO RAF AND MEK INHIBITORS (Fri, 16 Dec 2011)
>> Read More

HUMANIZED MONOCLONAL ANTIBODIES AND METHODS OF USE (Fri, 09 Dec 2011)
>> Read More

HUMANIZED MONOCLONAL ANTIBODIES AND METHODS OF USE (Fri, 09 Dec 2011)
>> Read More

Inhibition 0f inflammation using antagonists of MUC1 (Fri, 09 Dec 2011)
>> Read More

Soluble mTOR complexes and modulators thereof (Fri, 25 Nov 2011)
>> Read More

COMPOSITIONS AND METHODS FOR TREATING LEUKEMIA (Fri, 18 Nov 2011)
>> Read More

COMPOSITIONS AND METHODS FOR MODULATING METABOLISM (Fri, 18 Nov 2011)
>> Read More

MALE CONTRACEPTIVE COMPOSITIONS AND METHODS OF USE (Fri, 18 Nov 2011)
>> Read More

COMPOSITIONS AND METHODS FOR TREATING NEOPLASIA, INFLAMMATORY DISEASE AND OTHER DISORDERS (Fri, 18 Nov 2011)
>> Read More

COMPOSITIONS AND METHODS FOR MODULATING METABOLISM (Fri, 18 Nov 2011)
>> Read More

COMPOSITIONS AND METHODS FOR TREATING LEUKEMIA (Fri, 18 Nov 2011)
>> Read More

Site Search